je.st
news
The rise and fall of a revolutionary drug
2013-11-03 20:49:52| Biotech - Topix.net
Approved in May 2011, Vertex Pharmaceuticals' hepatitis C drug Incivek hit $457 million in sales in its second full quarter on the market.
Tags: fall
drug
rise
revolutionary
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||